Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women

Metabolic syndrome (MS) is increasingly recognized as an important cardiovascular risk factor in hypertension, but its influence on left ventricular (LV) mass and function in the 2 genders has not been specifically addressed. Among 618 nondiabetic, untreated hypertensive subjects, echocardiographically detected LV mass was significantly greater in subjects with MS. A significant interaction was observed between sex and the MS (P<0.003 for the multiplicative interaction term). Compared with women without the MS, those with the syndrome had a 24% greater LV mass (49.5±12 versus 40.0±10 g×m−2.7; P<0.001), whereas the difference was only 9% in men (50.3±12 versus 46.1±10 g×m−2.7; P=0.003). A greater prevalence of LV hypertrophy was found in women (37% versus 14%; P<0.001) but not in men (39% versus 29%; P=0.09) with the MS. After adjustment for the effect of age, body mass index, 24-hour systolic blood pressure, and several confounders, the MS was independently associated with a greater LV mass index in women (regression coefficient, 4.80; P<0.001) but not in men. Women with the MS also had a greater LV relative wall thickness (0.42±0.07 versus 0.39±0.07; P=0.004) and a depressed afterload-corrected midwall fractional shortening (94.0±12% versus 101.0±13%; P<0.001) than women without the syndrome, whereas no differences emerged in men. We conclude that, in untreated hypertension, MS has a different impact on LV hypertrophy and function in men and women. The effect of MS is more pronounced in women and is partly independent from the effect of several hemodynamic and nonhemodynamic determinants of LV mass.

[1]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[2]  Daniel W. Jones,et al.  Metabolic Syndrome and Echocardiographic Left Ventricular Mass in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study , 2005, Circulation.

[3]  L. Tavazzi,et al.  Metabolic syndrome and risk of cardiovascular events after myocardial infarction. , 2005, Journal of the American College of Cardiology.

[4]  D. Tanné,et al.  Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack: A Prospective Cohort Study in Patients With Atherosclerotic Cardiovascular Disease , 2005, Stroke.

[5]  G. Cerasola,et al.  Influence of metabolic syndrome on hypertension‐related target organ damage , 2005, Journal of internal medicine.

[6]  B. Paulweber,et al.  The Metabolic Syndrome Is a Stronger Risk Factor for Early Carotid Atherosclerosis in Women Than in Men , 2005, Stroke.

[7]  E. Mannarino,et al.  Metabolic Syndrome Is Associated With Aortic Stiffness in Untreated Essential Hypertension , 2005, Hypertension.

[8]  G. Leoncini,et al.  Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients , 2005, Journal of internal medicine.

[9]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[10]  F. Magrini,et al.  Metabolic syndrome and target organ damage in untreated essential hypertensives , 2004, Journal of hypertension.

[11]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[12]  E. Mannarino,et al.  Prognostic value of the metabolic syndrome in essential hypertension. , 2004, Journal of the American College of Cardiology.

[13]  D. Rizzoni,et al.  Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients , 2004, Hypertension.

[14]  L. Bouter,et al.  Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. , 2004, Diabetes care.

[15]  Christine M. Williams,et al.  Lipid metabolism in women , 2004, Proceedings of the Nutrition Society.

[16]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[17]  S. Lipsitz,et al.  Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. , 2003, Archives of internal medicine.

[18]  B. Howard,et al.  An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study. , 2003, Annals of epidemiology.

[19]  D. Levy,et al.  Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study , 2003, Circulation.

[20]  A. Onat,et al.  Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation. , 2002, Atherosclerosis.

[21]  G. de Simone,et al.  Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. , 2002, Journal of the American College of Cardiology.

[22]  G. Reboldi,et al.  Left ventricular mass and systolic dysfunction in essential hypertension , 2002, Journal of Human Hypertension.

[23]  Yuling Hong,et al.  Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study , 2002, Journal of hypertension.

[24]  E. Mannarino,et al.  High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension , 2001, Journal of hypertension.

[25]  H. Wellens,et al.  17&bgr;-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy , 2001, Circulation.

[26]  R. Devereux,et al.  Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study , 2001, Circulation.

[27]  G. Mensah,et al.  Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension , 2001, Journal of hypertension.

[28]  S. Pede,et al.  Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure. , 2000, The American journal of cardiology.

[29]  P. Verdecchia,et al.  Prognostic value of ambulatory blood pressure : current evidence and clinical implications. , 2000, Hypertension.

[30]  C Cosco,et al.  Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. , 2000, Hypertension.

[31]  S. Thom,et al.  Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. , 1999, American journal of hypertension.

[32]  B. Howard,et al.  Adverse Effects of Diabetes on Multiple Cardiovascular Disease Risk Factors in Women: The Strong Heart Study , 1998, Diabetes Care.

[33]  S. Daniels,et al.  Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. , 1998, Hypertension.

[34]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[35]  G. Reboldi,et al.  Prognostic significance of serial changes in left ventricular mass in essential hypertension. , 1998, Circulation.

[36]  G. Schillaci,et al.  Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension , 1996, Journal of hypertension.

[37]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[38]  J. Laragh,et al.  Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. , 1996, Circulation.

[39]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[40]  W. Gaasch,et al.  Left Ventricular Midwall Mechanics in Systemic Arterial Hypertension Myocardial Function is Depressed in Pressure‐Overload Hypertrophy , 1991, Circulation.

[41]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[42]  A. Kissebah,et al.  The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. , 1989, The Journal of clinical endocrinology and metabolism.

[43]  B. Howard,et al.  Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). , 2004, The American journal of cardiology.

[44]  J. Baron,et al.  World Wide Web at: , 2001 .

[45]  R Gorlin,et al.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.

[46]  Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension Prognosis , 2022 .